Company: RGBP
Filing Date: 2025-02-24
Form Type: 253G1
Source: 0001493152-25-008067
Chunk: 65

Company: Regen BioPharma Inc
Filing Date: 2025-02-24
Form: 253G1
Chunk 65
---
 in connection with the Equity Line Agreement in a Registration Statement to be filed with the Securities and Exchange Commission. Up to 1,126,954 Shares of Common Stock were registered for resale under the Securities Act of 1933 pursuant to the Registration Rights Agreement.

During the quarter ended December 31, 2023 the Company issued 244,199 common shares pursuant to the Equity Line Agreement for aggregate cash consideration of $212,296. During the Quarter ended March 31, 2024 the Company issued 364,057 common shares pursuant to the Equity Line Agreement for aggregate cash consideration of $187,937. During the Quarter ended June 30, 2024 the Company issued 258,456 common shares pursuant to the Equity Line Agreement for aggregate cash consideration of $135,326. During the Quarter ended September 30, 2024 the Company issued 135,242 common shares pursuant to the Equity Line Agreement for aggregate cash consideration of $28,126

NOTE 4. NOTES PAYABLE

(a) RELATED PARTY

|                           |     | As of September 30, 2024 |        |
|:--------------------------|:----|:-------------------------|-------:|
| David Koos                |     | $                        |  1,708 |
| Zander Therapeutics, Inc. |     | $                        | 40,000 |
| Total:                    |     |                          |      $ 
 41,708 |

$1,708 lent to the Company by David Koos is due and payable at the demand of the holder and bears simple interest at a rate of 15% per annum.

$15,000 lent to the Company by Zander Therapeutics, Inc. is due and payable on May 3. 2025 and bears simple interest at a rate of 10% per annum.

$25,000 lent to the Company by Zander Therapeutics, Inc. is due and payable on June 5. 2025 and bears simple interest at a rate of 10% per annum.

Zander Therapeutics, Inc. and the Company are under common control.

| 52 |

(b) NON RELATED PARTY As of September 30, 2024

| Bostonia Partners, Inc.  |     | $ |  48,500 |
| Coventry Enterprises LLC |     | $ | 250,000 |
| Total:                   |     | $ | 298,500 |

$48,500 lent to the Company by Bostonia Partners, Inc is due